Search Results 351-360 of 13285 for testosterone

  1. Dr. Tobias Kohler Archives - Mayo Clinic News Network

    ... testosterone, prostate and colon, anxiety or other medical issues. Journalists who have already registered on the News Network can log into their accounts ...

  2. A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    Maintain castrate levels of testosterone within 4 weeks prior to randomization and throughout the study; Patients currently receiving bone loss prevention ...

  3. Paclitaxel protein-bound (intravenous route) - Mayo Clinic

    Testosterone; Tretinoin; Typhoid Vaccine, Live; Yellow Fever Vaccine. Other Interactions. Certain medicines should not be used at or around the time of eating ...

  4. Publications - Brooke M. Katzman, Ph.D. - Mayo Clinic

    Suspected Testosterone-Producing Tumor in a Patient Taking Biotin Supplements. J Endocr Soc. 2018 Jun 1; 2 (6):563-569 Epub 2018 May 10. View PubMed; Huang MB ...

  5. Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer - Mayo Clinic

    Testosterone > 50 ng/dL within 90 days prior to Step 1 registration. Concomitant medications known to lower the seizure threshold discontinued or ...

  6. Levoketoconazole (oral route) - Mayo Clinic

    This medicine may decrease testosterone levels in men and women. Check with your doctor right away if you have decreased interest in sexual intercourse ...

  7. Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery - Mayo Clinic

    Baseline testosterone level obtained post prostatectomy prior to step 1 registration; Pathologically (histologically) proven diagnosis of adenocarcinoma of ...

  8. SBRT for Oligometastatic Castration-Refractory Prostate Cancer - Mayo Clinic

    Castrate levels of testosterone; Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ≤ 2 (Appendix I). Life expectancy > 6 months. Exclusion ...

  9. A Study of Carboplatin, Cabazitaxel and Abiraterone in High Volume Metastatic Castration Sensitive Prostate Cancer (CASCARA) - Mayo Clinic

    Testosterone 1 month prior to study treatment start. Patients must continue primary ADT with an LHRH analogue if they have not undergone orchiectomy ...

  10. Estrogen (oral route, parenteral route, topical application route, transdermal route) - Mayo Clinic

    Other conditions include a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), or ovary problems (female hypogonadism or ...